Fluoxetine-induced	fluoxetine-induced	O	O	O	O
akathisia	akathisia	O	DISEASE	OTHERS	I
:	:	O	O	O	O
clinical	clinical	O	O	O	O
and	and	O	O	O	O
theoretical	theoretical	O	O	O	O
implications	implications	O	O	O	O
.	.	O	O	O	O

Five	five	O	O	O	O
patients	patients	O	O	O	O
receiving	receiving	O	O	O	O
fluoxetine	fluoxetine	CHEMICALS	O	OTHERS	I
for	for	O	O	O	O
the	the	O	O	O	O
treatment	treatment	O	O	O	O
of	of	O	O	O	O
obsessive	obsessive	O	O	OTHERS	I
compulsive	compulsive	O	O	OTHERS	I
disorder	disorder	O	O	OTHERS	I
or	or	O	O	O	O
major	major	O	DISEASE	OTHERS	I
depression	depression	O	DISEASE	OTHERS	I
developed	developed	O	O	O	O
akathisia	akathisia	O	DISEASE	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
typical	typical	O	O	O	O
fluoxetine-induced	fluoxetine-induced	O	O	O	O
symptoms	symptoms	O	O	O	O
of	of	O	O	O	O
restlessness	restlessness	O	DISEASE	OTHERS	I
,	,	O	O	O	O
constant	constant	O	O	O	O
pacing	pacing	O	O	O	O
,	,	O	O	O	O
purposeless	purposeless	O	O	O	O
movements	movements	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
feet	feet	O	O	O	O
and	and	O	O	O	O
legs	legs	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
marked	marked	O	O	O	O
anxiety	anxiety	O	DISEASE	OTHERS	I
were	were	O	O	O	O
indistinguishable	indistinguishable	O	O	O	O
from	from	O	O	O	O
those	those	O	O	O	O
of	of	O	O	O	O
neuroleptic-induced	neuroleptic-induced	O	O	O	O
akathisia	akathisia	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Three	three	O	O	O	O
patients	patients	O	O	O	O
who	who	O	O	O	O
had	had	O	O	O	O
experienced	experienced	O	O	O	O
neuroleptic-induced	neuroleptic-induced	O	O	O	O
akathisia	akathisia	O	DISEASE	OTHERS	I
in	in	O	O	O	O
the	the	O	O	O	O
past	past	O	O	O	O
reported	reported	O	O	O	O
that	that	O	O	O	O
the	the	O	O	O	O
symptoms	symptoms	O	O	O	O
of	of	O	O	O	O
fluoxetine-induced	fluoxetine-induced	O	O	O	O
akathisia	akathisia	O	DISEASE	OTHERS	I
were	were	O	O	O	O
identical	identical	O	O	O	O
,	,	O	O	O	O
although	although	O	O	O	O
somewhat	somewhat	O	O	O	O
milder	milder	O	O	O	O
.	.	O	O	O	O

Akathisia	akathisia	O	DISEASE	OTHERS	I
appeared	appeared	O	O	O	O
to	to	O	O	O	O
be	be	O	O	O	O
a	a	O	O	O	O
common	common	O	O	O	O
side	side	O	O	O	O
effect	effect	O	O	O	O
of	of	O	O	O	O
fluoxetine	fluoxetine	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
generally	generally	O	O	O	O
responded	responded	O	O	O	O
well	well	O	O	O	O
to	to	O	O	O	O
treatment	treatment	O	O	O	O
with	with	O	O	O	O
the	the	O	O	O	O
beta-adrenergic	beta-adrenergic	O	O	O	O
antagonist	antagonist	O	O	O	O
propranolol	propranolol	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
dose	dose	O	O	O	O
reduction	reduction	O	O	O	O
,	,	O	O	O	O
or	or	O	O	O	O
both	both	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
authors	authors	O	O	O	O
suggest	suggest	O	O	O	O
that	that	O	O	O	O
fluoxetine-induced	fluoxetine-induced	O	O	O	O
akathisia	akathisia	O	DISEASE	OTHERS	I
may	may	O	O	O	O
be	be	O	O	O	O
caused	caused	O	O	O	O
by	by	O	O	O	O
serotonergically	serotonergically	O	O	O	O
mediated	mediated	O	O	O	O
inhibition	inhibition	O	O	O	O
of	of	O	O	O	O
dopaminergic	dopaminergic	O	O	O	O
neurotransmission	neurotransmission	O	O	O	O
and	and	O	O	O	O
that	that	O	O	O	O
the	the	O	O	O	O
pathophysiology	pathophysiology	O	O	O	O
of	of	O	O	O	O
fluoxetine-induced	fluoxetine-induced	O	O	O	O
akathisia	akathisia	O	DISEASE	OTHERS	I
and	and	O	O	O	O
tricyclic	tricyclic	O	O	O	O
antidepressant-induced	antidepressant-induced	O	O	O	O
"	"	O	O	O	O
jitteriness	jitteriness	O	O	O	O
"	"	O	O	O	O
may	may	O	O	O	O
be	be	O	O	O	O
identical	identical	O	O	O	O
.	.	O	O	O	O

